These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 11494398

  • 1. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB.
    Synapse; 2001 Sep 15; 41(4):275-84. PubMed ID: 11494398
    [Abstract] [Full Text] [Related]

  • 2. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep 15; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 3. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB.
    J Nucl Med; 1996 Feb 15; 37(2):222-8. PubMed ID: 8667048
    [Abstract] [Full Text] [Related]

  • 4. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE, Choi JY, Choe YS, Choi Y, Lee WY.
    J Nucl Med; 2003 Jun 15; 44(6):870-6. PubMed ID: 12791812
    [Abstract] [Full Text] [Related]

  • 5. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB.
    J Nucl Med; 1997 Sep 15; 38(9):1453-9. PubMed ID: 9293807
    [Abstract] [Full Text] [Related]

  • 6. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL.
    Synapse; 1993 Apr 15; 13(4):295-309. PubMed ID: 7683143
    [Abstract] [Full Text] [Related]

  • 7. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE, al-Tikriti MS, Gandelman MS, Laruelle M, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Hoffer PB, Charney DS, Wang S.
    Eur J Nucl Med; 1995 Jan 15; 22(1):4-11. PubMed ID: 7698153
    [Abstract] [Full Text] [Related]

  • 8. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.
    J Nucl Med; 2000 Jan 15; 41(1):36-44. PubMed ID: 10647603
    [Abstract] [Full Text] [Related]

  • 9. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Kim SE, Lee WY, Choe YS, Kim JH.
    Neurol Res; 1999 Apr 15; 21(3):255-61. PubMed ID: 10319333
    [Abstract] [Full Text] [Related]

  • 10. Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking.
    Cosgrove KP, Krantzler E, Frohlich EB, Stiklus S, Pittman B, Tamagnan GD, Baldwin RM, Bois F, Seibyl JP, Krystal JH, O'Malley SS, Staley JK.
    Neuropsychopharmacology; 2009 Sep 15; 34(10):2218-26. PubMed ID: 19440191
    [Abstract] [Full Text] [Related]

  • 11. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
    Laruelle M, Giddings SS, Zea-Ponce Y, Charney DS, Neumeyer JL, Baldwin RM, Innis RB.
    J Neurochem; 1994 Mar 15; 62(3):978-86. PubMed ID: 8113817
    [Abstract] [Full Text] [Related]

  • 12. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB.
    J Nucl Med; 1995 Jul 15; 36(7):1175-81. PubMed ID: 7790941
    [Abstract] [Full Text] [Related]

  • 13. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
    Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R.
    Biol Psychiatry; 2000 Mar 01; 47(5):371-9. PubMed ID: 10704949
    [Abstract] [Full Text] [Related]

  • 14. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG, Müller TT, Zander C, Kuhn W, Farahati J, Reiners C, Coenen HH.
    J Investig Med; 1997 Oct 01; 45(8):448-52. PubMed ID: 9394097
    [Abstract] [Full Text] [Related]

  • 15. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB.
    J Nucl Med; 1996 Jul 01; 37(7):1129-33. PubMed ID: 8965183
    [Abstract] [Full Text] [Related]

  • 16. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W.
    Brain; 2005 Jul 01; 128(Pt 7):1605-12. PubMed ID: 15817519
    [Abstract] [Full Text] [Related]

  • 17. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.
    Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB.
    Am J Psychiatry; 1998 Jun 01; 155(6):832-4. PubMed ID: 9619159
    [Abstract] [Full Text] [Related]

  • 18. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA, Kuikka JT, Ahonen A, Vanninen E.
    J Nucl Biol Med (1991); 1994 Dec 01; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [Abstract] [Full Text] [Related]

  • 19. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.
    Tissingh G, Bergmans P, Booij J, Winogrodzka A, van Royen EA, Stoof JC, Wolters EC.
    J Neurol; 1998 Jan 01; 245(1):14-20. PubMed ID: 9457623
    [Abstract] [Full Text] [Related]

  • 20. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA.
    J Nucl Med; 1998 Nov 01; 39(11):1879-84. PubMed ID: 9829575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.